Nucleophosmin, also known as nucleolar phosphoprotein B23 or numatrin, is a protein that in humans is encoded by the NPM1 gene. From Wikipedia
A UK-led phase 3 trial demonstrates that molecular monitoring detects relapse earlier, enabling timely treatment and significantly improving outcomes.
